Human TNFSF10/Apo-2L/APO2L ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_003810.3)
Cat. No.: pGMPC000026
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human TNFSF10/Apo-2L/APO2L Non-Viral expression plasmid (overexpression vector) for mouse TNFSF10 overexpression in unique cell transient transfection and stable cell line development.
Go to
TRAIL/CD253/TNFSF10/TNFSF10/Apo-2L products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMPC000026 |
| Gene Name | TNFSF10 |
| Accession Number | NM_003810.3 |
| Gene ID | 8743 |
| Species | Human |
| Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
| Insert Length | 846 bp |
| Gene Alias | Apo-2L,APO2L,CD253,TL2,TNLG6A,TRAIL |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCTATGATGGAGGTCCAGGGGGGACCCAGCCTGGGACAGACCTGCGTGCTGATCGTGATCTTCACAGTGCTCCTGCAGTCTCTCTGTGTGGCTGTAACTTACGTGTACTTTACCAACGAGCTGAAGCAGATGCAGGACAAGTACTCCAAAAGTGGCATTGCTTGTTTCTTAAAAGAAGATGACAGTTATTGGGACCCCAATGACGAAGAGAGTATGAACAGCCCCTGCTGGCAAGTCAAGTGGCAACTCCGTCAGCTCGTTAGAAAGATGATTTTGAGAACCTCTGAGGAAACCATTTCTACAGTTCAAGAAAAGCAACAAAATATTTCTCCCCTAGTGAGAGAAAGAGGTCCTCAGAGAGTAGCAGCTCACATAACTGGGACCAGAGGAAGAAGCAACACATTGTCTTCTCCAAACTCCAAGAATGAAAAGGCTCTGGGCCGCAAAATAAACTCCTGGGAATCATCAAGGAGTGGGCATTCATTCCTGAGCAACTTGCACTTGAGGAATGGTGAACTGGTCATCCATGAAAAAGGGTTTTACTACATCTATTCCCAAACATACTTTCGATTTCAGGAGGAAATAAAAGAAAACACAAAGAACGACAAACAAATGGTCCAATATATTTACAAATACACAAGTTATCCTGACCCTATATTGTTGATGAAAAGTGCTAGAAATAGTTGTTGGTCTAAAGATGCAGAATATGGACTCTATTCCATCTATCAAGGGGGAATATTTGAGCTTAAGGAAAATGACAGAATTTTTGTTTCTGTAACAAATGAGCACTTGATAGACATGGACCATGAAGCCAGTTTTTTTGGGGCCTTTTTAGTTGGCTAA |
| ORF Protein Sequence | MAMMEVQGGPSLGQTCVLIVIFTVLLQSLCVAVTYVYFTNELKQMQDKYSKSGIACFLKEDDSYWDPNDEESMNSPCWQVKWQLRQLVRKMILRTSEETISTVQEKQQNISPLVRERGPQRVAAHITGTRGRSNTLSSPNSKNEKALGRKINSWESSRSGHSFLSNLHLRNGELVIHEKGFYYIYSQTYFRFQEEIKENTKNDKQMVQYIYKYTSYPDPILLMKSARNSCWSKDAEYGLYSIYQGGIFELKENDRIFVSVTNEHLIDMDHEASFFGAFLVG |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T46084-Ab | Anti-TNF10/ TNFSF10/ APO2L functional antibody |
| Target Antigen | GM-Tg-g-T46084-Ag | TNFSF10 protein |
| Cytokine | cks-Tg-g-GM-T46084 | tumor necrosis factor (ligand) superfamily, member 10 (TNFSF10) protein & antibody |
| ORF Viral Vector | pGMPC000026 | Human TNFSF10 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC000692 | Human TNFSF10 Mammalian (Non-Viral Vector) plasmid |
Target information
| Target ID | GM-T46084 |
| Target Name | TRAIL/CD253/TNFSF10 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
8743 |
| Gene ID |
100064377 (Equus caballus), 100174780 (Canis lupus familiaris), 100174789 (Felis catus), 22035 (Mus musculus) 246775 (Rattus norvegicus), 507215 (Bos taurus), 694451 (Macaca mulatta), 8743 (Homo sapiens) |
| Gene Symbols & Synonyms | TNFSF10,Tnfsf10,TNLG6A,TRAIL,TL2,Ly81,Trail,APO-2L,Tnlg6a,A330042I21Rik,APO2L,CD253,TANCR,Apo-2L |
| Target Alternative Names | A330042I21Rik,APO-2L,APO2L,Apo-2 ligand (Apo-2L),Apo-2L,CD253,Ly81,TANCR,TL2,TNF-related apoptosis-inducing ligand (Protein TRAIL),TNFSF10,TNLG6A,TRAIL,Tnfsf10,Tnlg6a,Trail,Tumor necrosis factor ligand superfamily member 10 |
| Uniprot Accession |
P50591,P50592
Additional SwissProt Accessions: P50592,P50591 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, Immuno-oncology Target, Cytokine Target |
| Disease | cancer, Prostate Cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, FoxO signaling pathway, Apoptosis, Natural killer cell mediated cytotoxicity, Pathogenic Escherichia coli infection, Influenza A, Lipid and atherosclerosis |
| Gene Ensembl | ENSECAG00000019391, ENSCAFG00845025786, ENSMUSG00000039304, ENSBTAG00000018994, ENSMMUG00000019302, ENSG00000121858 |
| Target Classification | Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


